Research Archive — Page 50 of 131
-
September 22, 2022
Nerve cells and cancer progression
Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression. -
September 15, 2022
Study suggests new mechanism for lipid transporter
A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought. -
September 13, 2022
Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial
Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib. -
September 13, 2022
Cancer registries and sarcoma research
The number of sarcoma research studies that use the two largest U.S. cancer registries is increasing, but over one-third of studies that asked the same research question reported conflicting findings. -
September 12, 2022
Enhancing innate immunity in the lung
Vanderbilt researchers show that a TLR4 agonist improves lung immune response and survival in a mouse model of bacterial pneumonia, supporting the development of this drug to protect against pneumonia in hospitalized patients. -
September 8, 2022
PheWAS reveals post-COVID-19 diagnoses
Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses. -
September 8, 2022
Immune cells drive beta cell loss in Type 2 diabetes
Vanderbilt researchers have discovered details of pancreatic beta cell loss — and potential therapeutic targets — during conditions of overnutrition, as occurs in obesity.